Profile
| Metric | Value |
|---|---|
| Full Name | Hologic, Inc. |
| Ticker | NASDAQ: HOLX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | |
| Website | hologic.com |
| Employees | 7,063 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $74.88 | |
| Price, 1D Change | -0.11% | |
| Market Cap | $17B | |
| - | ||
| PE Ratio | 30.16 | |
| Beta | 0.31 | |
| Revenue | $4B | |
| Revenue, 1Y Change | +1.74% | |
| EPS | $2.49 | |
| EPS, 1Y Change | -25.21% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $2.49 | |
| EPS Estimate | N/A | $4.56 |
| EPS Est. Change | N/A | +83.27% |
| Revenue | $4.10B | |
| Revenue Estimate | N/A | $4.28B |
| Revenue Est. Change | N/A | +4.49% |
| Current Price | $74.88 | |
| Price Target | - | $77.00 |
| Price Tgt. Change | - | +2.83% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.08 | $3.32 | -18.54% | |
| $4.24 | $2.49 | -41.34% | |
| $4.56 | N/A | +83.27% | |
| $5.00 | N/A | +100.95% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.02B | $4.03B | +0.26% | |
| $4.09B | $4.10B | +0.37% | |
| $4.28B | N/A | +4.49% | |
| $4.51B | N/A | +10.00% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +2.94% | |
| Price, 3Y | -3.79% | |
| Market Cap, 1Y | +1.66% | |
| Market Cap, 3Y | -13.02% | |
| Revenue, 1Y | +1.74% | |
| Revenue, 3Y | -15.68% | |
| EPS, 1Y | -25.21% | |
| EPS, 3Y | -51.54% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $74.88 | |
| SMA 200 | $66.61 | |
| SMA 200 vs Price | -11.04% | |
| SMA 50 | $74.58 | |
| SMA 50 vs Price | -0.40% | |
| Beta | 0.31 | |
| ATR | $0.27 | |
| 14-Day RSI | 58.82 | |
| 10-Day Volatility | 3.26% | |
| 1-Year Volatility | 28.84% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $4.10B | |
| EPS | $2.49 | |
| Gross Profit | $2.10B | |
| Gross Margin | 51.30% | |
| Operating Profit | $785.40M | |
| Operating Margin | 19.15% | |
| Net Income | $565.70M | |
| Net Margin | 13.80% | |
| EBITDA | $1.09B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.50 | |
| Current Ratio | 3.75 | |
| Quick Ratio | 3.06 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 4.15 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 30.16 | |
| PS Ratio | 4.07 | |
| PB Ratio | 3.31 | |
| EV/EBITDA | 13.60 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $5.05B | |
| Cash & Equivalents | $2.20B | |
| Total Assets | $9.01B | |
| Current Assets | $3.67B | |
| Total Liabilities | $3.97B | |
| Current Liabilities | $977.20M | |
| Total Debt | $2.63B | |
| Short Term Debt | $33.40M | |
| Accounts Payable | $193.40M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $3.53B | |
| Operating Expenses | $1.32B | |
| Cost Of Goods Sold | $2.00B | |
| SG&A | $0.00 | |
| D&A | $299.80M | |
| Interest Expense | $0.00 | |
| Income Tax | $115.50M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $1.06B | |
| CFI | -$482.70M | |
| CFF | -$777.20M | |
| Capex | $152.40M | |
| Free Cash Flow | $904.70M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | → | |
| Morgan Stanley | → | |
| Mizuho | → | |
| Stephens & Co. | → | |
| Raymond James | → | |
| JP Morgan | → | |
| Needham | → | |
| Leerink Partners | → | |
| BTIG | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
Screeners with HOLX
Data Sources & References
- HOLX Official Website www.hologic.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/859737/000119312525244423/0001193125-25-244423-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/859737/000119312525244423/0001193125-25-244423-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- HOLX Profile on Yahoo Finance finance.yahoo.com/quote/HOLX
- HOLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/holx
FAQ
What is the ticker symbol for Hologic, Inc.?
The ticker symbol for Hologic, Inc. is NASDAQ:HOLX
Does Hologic, Inc. pay dividends?
No, Hologic, Inc. does not pay dividends
What sector is Hologic, Inc. in?
Hologic, Inc. is in the Healthcare sector
What industry is Hologic, Inc. in?
Hologic, Inc. is in the Medical Instruments & Supplies industry
What country is Hologic, Inc. based in?
Hologic, Inc. is headquartered in United States
When did Hologic, Inc. go public?
Hologic, Inc. initial public offering (IPO) was on March 1, 1990
Is Hologic, Inc. in the S&P 500?
Yes, Hologic, Inc. is included in the S&P 500 index
Is Hologic, Inc. in the NASDAQ 100?
No, Hologic, Inc. is not included in the NASDAQ 100 index
Is Hologic, Inc. in the Dow Jones?
No, Hologic, Inc. is not included in the Dow Jones index
When was Hologic, Inc. last earnings report?
Hologic, Inc.'s most recent earnings report was on November 3, 2025
When does Hologic, Inc. report earnings?
The next expected earnings date for Hologic, Inc. is February 4, 2026